Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose- and 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography as biomarkers of therapy response in platinum-resistant ovarian cancer. [electronic resource]
Producer: 20130501Description: 753-61 p. digitalISSN:- 1860-2002
- Animals
- Biomarkers, Tumor -- metabolism
- Blotting, Western
- Cell Line, Tumor
- Chlorpropamide -- analogs & derivatives
- Dideoxynucleosides -- pharmacokinetics
- Drug Resistance, Neoplasm -- drug effects
- Female
- Fluorodeoxyglucose F18 -- pharmacokinetics
- Humans
- Ki-67 Antigen -- metabolism
- Mice
- Ovarian Neoplasms -- diagnostic imaging
- Platinum -- pharmacology
- Positron-Emission Tomography
- Time Factors
- Treatment Outcome
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.